Literature DB >> 29928922

Mast cell activation syndrome: Importance of consensus criteria and call for research.

Peter Valent1, Cem Akin2, Patrizia Bonadonna3, Karin Hartmann4, Sigurd Broesby-Olsen5, Knut Brockow6, Joseph H Butterfield7, Andreas Reiter8, Jason Gotlib9, Mariana Castells10, Joshua D Milner11, Melody C Carter11, Hirsh Komarow11, Deepti Radia12, Animesh Pardanani13, Karl Sotlar14, Massimo Triggiani15, Hans-Peter Horny16, Michel Arock17, Lawrence B Schwartz18, Dean D Metcalfe11.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29928922      PMCID： PMC7115848          DOI： 10.1016/j.jaci.2018.06.004

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

2.  Mast cell activation syndrome: Proposed diagnostic criteria.

Authors:  Cem Akin; Peter Valent; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2010-10-28       Impact factor: 10.793

3.  Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.

Authors:  Cem Akin; Linda M Scott; Can N Kocabas; Nataliya Kushnir-Sukhov; Erica Brittain; Pierre Noel; Dean D Metcalfe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

Review 4.  Mast cell activation syndromes.

Authors:  Cem Akin
Journal:  J Allergy Clin Immunol       Date:  2017-08       Impact factor: 10.793

5.  Validation of international consensus equation for acute serum total tryptase in mast cell activation: A perioperative perspective.

Authors:  R L Baretto; S Beck; J Heslegrave; C Melchior; O Mohamed; A Ekbote; A P Huissoon; M T Krishna
Journal:  Allergy       Date:  2017-07-12       Impact factor: 13.146

6.  A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.

Authors:  Melody C Carter; Avanti Desai; Hirsh D Komarow; Yun Bai; Sarah T Clayton; Alicia S Clark; Karina N Ruiz-Esteves; Lauren M Long; Daly Cantave; Todd M Wilson; Linda M Scott; Olga Simakova; Mi-Yeon Jung; Jamie Hahn; Irina Maric; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2017-06-16       Impact factor: 10.793

7.  Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.

Authors:  Jonathan J Lyons; Xiaomin Yu; Jason D Hughes; Quang T Le; Ali Jamil; Yun Bai; Nancy Ho; Ming Zhao; Yihui Liu; Michael P O'Connell; Neil N Trivedi; Celeste Nelson; Thomas DiMaggio; Nina Jones; Helen Matthews; Katie L Lewis; Andrew J Oler; Ryan J Carlson; Peter D Arkwright; Celine Hong; Sherene Agama; Todd M Wilson; Sofie Tucker; Yu Zhang; Joshua J McElwee; Maryland Pao; Sarah C Glover; Marc E Rothenberg; Robert J Hohman; Kelly D Stone; George H Caughey; Theo Heller; Dean D Metcalfe; Leslie G Biesecker; Lawrence B Schwartz; Joshua D Milner
Journal:  Nat Genet       Date:  2016-10-17       Impact factor: 38.330

8.  Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.

Authors:  Anupama Ravi; Joseph Butterfield; Catherine R Weiler
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-06

9.  The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.

Authors:  L B Schwartz; K Sakai; T R Bradford; S Ren; B Zweiman; A S Worobec; D D Metcalfe
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808
  9 in total
  5 in total

Review 1.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

Review 2.  Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.

Authors:  Peter Valent; Cem Akin; Patrizia Bonadonna; Karin Hartmann; Knut Brockow; Marek Niedoszytko; Boguslaw Nedoszytko; Frank Siebenhaar; Wolfgang R Sperr; Joanna N G Oude Elberink; Joseph H Butterfield; Ivan Alvarez-Twose; Karl Sotlar; Andreas Reiter; Hanneke C Kluin-Nelemans; Olivier Hermine; Jason Gotlib; Sigurd Broesby-Olsen; Alberto Orfao; Hans-Peter Horny; Massimo Triggiani; Michel Arock; Lawrence B Schwartz; Dean D Metcalfe
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-05

Review 3.  Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.

Authors:  Peter Valent; Patrizia Bonadonna; Karin Hartmann; Sigurd Broesby-Olsen; Knut Brockow; Joseph H Butterfield; Massimo Triggiani; Jonathan J Lyons; Joanna N G Oude Elberink; Michel Arock; Dean D Metcalfe; Cem Akin
Journal:  Int Arch Allergy Immunol       Date:  2019-06-28       Impact factor: 2.749

Review 4.  Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease.

Authors:  Saptarshi Roy; Chalatip Chompunud Na Ayudhya; Monica Thapaliya; Vishwa Deepak; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2021-05-04       Impact factor: 14.290

Review 5.  Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives.

Authors:  Sarah C Beck; Thomas Wilding; Richard J Buka; Richard L Baretto; Aarnoud P Huissoon; Mamidipudi T Krishna
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.